Source:http://linkedlifedata.com/resource/pubmed/id/19914334
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-1
|
pubmed:abstractText |
The pathophysiological process of schizophrenia is still unclear. The levels of interleukine-6 (IL-6) and its receptor, soluble IL-6R, have been reported to be elevated in the plasma and cerebrospinal fluid of schizophrenic patients. In this study, we tested the association of genetic variants of IL-6 and IL-6R with schizophrenia. Genotyping of three single nucleotide polymorphisms (SNP) for each IL-6 (IL-6-1, IL-6-2, and IL-6-3) and IL-6R (rs4845617=IL-6R1, rs4553185=IL-6R2, and rs4379670=IL-6R3) gene was performed in 100 patients with schizophrenia and 113 normal controls. The polymorphisms of IL-6R2 were genotyped using Tetra-primer ARMS PCR. IL-6R3 polymorphisms were genotyped using restriction fragment length polymorphism (RFLP) with Apo I enzyme as the restriction enzyme. All other polymorphisms were genotyped using the direct sequencing method. We found a di-nucleotide haplotype block and a tri-nucleotide haplotype block in the genes of IL-6 and IL-6R, respectively. All six SNPs and their haplotypes failed to show a significant association with schizophrenia. The IL-6-2 SNP showed a nominally significant association with the positive symptoms of schizophrenia (p=0.0472). We conclude that the genetic variants of IL-6 and IL-6R are not associated with schizophrenia. In order to verify this result, further study using a larger sample size and exploring the association between the genotype of IL-6-2 and plasma level of IL-6 is recommended.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1872-7972
|
pubmed:author |
pubmed-author:ChanHung-YuHY,
pubmed-author:ChenJiann-JyhJJ,
pubmed-author:ChenWei JWJ,
pubmed-author:ChenYa-HuiYH,
pubmed-author:FannCathy Shen-JangCS,
pubmed-author:HsiehMing HMH,
pubmed-author:HwangTzung-JengTJ,
pubmed-author:HwuHai-GwoHG,
pubmed-author:LiuChih-MinCM,
pubmed-author:LiuShih-KaiSK,
pubmed-author:LiuYu-LiYL,
pubmed-author:TsengLi-JungLJ,
pubmed-author:YangWei ChihWC
|
pubmed:copyrightInfo |
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
468
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
330-3
|
pubmed:meshHeading |
pubmed-meshheading:19914334-Adult,
pubmed-meshheading:19914334-Asian Continental Ancestry Group,
pubmed-meshheading:19914334-Female,
pubmed-meshheading:19914334-Genetic Association Studies,
pubmed-meshheading:19914334-Genetic Predisposition to Disease,
pubmed-meshheading:19914334-Humans,
pubmed-meshheading:19914334-Interleukin-6,
pubmed-meshheading:19914334-Male,
pubmed-meshheading:19914334-Polymorphism, Single Nucleotide,
pubmed-meshheading:19914334-Receptors, Interleukin-6,
pubmed-meshheading:19914334-Schizophrenia,
pubmed-meshheading:19914334-Taiwan
|
pubmed:year |
2010
|
pubmed:articleTitle |
Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan.
|
pubmed:affiliation |
Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, National Health Research Institute, Miao-Li, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|